These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6245569)

  • 41. PGE1 and prostacyclin suppression of NK-cell mediated cytotoxicity and its relation to cyclic AMP.
    Lanefelt F; Ullberg M; Jondal M; Fredholm BB
    Med Biol; 1983; 61(6):324-30. PubMed ID: 6328136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of prostacyclin and prostaglandin E1 on cyclic AMP metabolism and calcium efflux in isolated renal cortical tubules.
    Biddulph DM; Currie MG; Wrenn RW
    Prostaglandins Med; 1980 Nov; 5(5):391-403. PubMed ID: 6161383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
    Konturek SJ
    Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
    [No Abstract]   [Full Text] [Related]  

  • 44. Pulmonary and systemic vascular effects of exogenous prostaglandin I2 in fetal lambs.
    Leffler CW; Hessler JR
    Eur J Pharmacol; 1979 Feb; 54(1-2):37-42. PubMed ID: 369870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Agonist-specific desensitization of PGI2-stimulated cyclic AMP accumulation by PGE1 in human foreskin fibroblasts.
    Gorman RR; Hopkins NK
    Prostaglandins; 1980 Jan; 19(1):2-16. PubMed ID: 6247745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hemodynamic reaction of normotensive and hypertensive rats to the administration of prostaglandins and indomethacin].
    Ismailov ShI; Val'dman AV
    Biull Eksp Biol Med; 1982 Aug; 94(8):45-8. PubMed ID: 6751430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostaglandin E2 and central cyclic nucleotides.
    Folco GC; Longiave D; Berti F; Fumagalli R; Paoletti R
    Adv Prostaglandin Thromboxane Res; 1976; 1():305-12. PubMed ID: 187044
    [No Abstract]   [Full Text] [Related]  

  • 48. Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids.
    Hyman AL; Chapnick BM; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5711-5. PubMed ID: 414226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of PGI2 in patients with ischemic heart disease--coronary dilator action of prostacyclin and dissolution of coronary spasms observed in coronary angiography].
    Saito S; Tsuzi M; Tamura Y; Tomobe K; Tokutake E; Yumikura S; Hibiya K; Yamamoto M; Ichikawa M; Honda M; Ozawa Y; Hatano M
    Kokyu To Junkan; 1982 Oct; 30(10):1033-8. PubMed ID: 6760309
    [No Abstract]   [Full Text] [Related]  

  • 50. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
    Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
    J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs.
    Jugdutt BI; Hutchins GM; Bulkley BH; Becker LC
    Circ Res; 1981 Sep; 49(3):685-700. PubMed ID: 7020976
    [No Abstract]   [Full Text] [Related]  

  • 52. Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.
    Warrington SJ; Smith PR; O'Grady J
    Eur J Cardiol; 1980; 12(2):73-80. PubMed ID: 7002563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of prostacyclin on some hemodynamic parameters in dogs.
    Filczewski M; Oledzka K
    Pol J Pharmacol Pharm; 1981; 33(5):491-8. PubMed ID: 7038645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of PGE2 on the cyclic nucleotide content of isolated neonatal rat pancreatic islets treated with alloxan].
    Wang JL; Zhao YL; Song Y; Zhu WY
    Sheng Li Xue Bao; 1986 Aug; 38(4):403-8. PubMed ID: 3026054
    [No Abstract]   [Full Text] [Related]  

  • 55. Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro.
    Schrör K; Link HB; Rösen R; Klaus W; Rösen P
    Eur J Pharmacol; 1980 Jun; 64(4):341-8. PubMed ID: 6156077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
    Aiken JW; Shebuski RJ
    Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart.
    Kowey PR; Verrier RL; Lown B
    Eur J Pharmacol; 1982 May; 80(1):83-91. PubMed ID: 7047179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of prostacyclin on the fetal pulmonary circulation.
    Cassin S; Winikor I; Tod M; Philips J; Frisinger J; Jordan J; Gibbs C
    Pediatr Pharmacol (New York); 1981; 1(3):197-207. PubMed ID: 7050867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of the antithrombotic effect of prostacyclin by simultaneous administration of aminophylline in a canine model of coronary artery thrombosis.
    Romson JL; Hook BG; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):288-94. PubMed ID: 6313894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of PGI2 and PGI2 analogues with increased stability on platelet cAMP content and aggregation.
    Blaskó G; Nemesánszky E; Szabó G; Stadler I; Pálos LA
    Thromb Res; 1980 Mar; 17(5):673-81. PubMed ID: 6247777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.